BORTEZOMIBE
Country: Brazil
Language: Portuguese
Source: ANVISA (Agência Nacional de Vigilância Sanitária)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BORTEZOMIBE
Available from:
LABORATÓRIO QUÍMICO FARMACÊUTICO BERGAMO LTDA
ATC code:
ANTINEOPLASICOS CITOTOXICOS
INN (International Name):
BORTEZOMIBE
Therapeutic area:
ANTINEOPLASICOS CITOTOXICOS
Product summary:
3,5 MG PO LIOF SOL INJ CT FA VD TRANS - 1064602080012 - Venda sob Prescrição Médica - ENDOVENOSA/INTRAVENOSA, SUBCUTÂNEA - Pó Liofilizado para Solução Injetável
Authorization status:
Válido
Authorization date:
2018-04-02
